Article
A broad matrix metalloproteinase inhibitor with designed loop extension exhibits ultrahigh specificity for MMP-14
2022-12-29
Abstract excerpt
Matrix metalloproteinases (MMPs) are key drivers of various diseases, including cancer. While several antibodies against MMPs are in development, our goal is to construct therapeutic anti-MMP inhibitors based on a natural broad MMP inhibitor, tissue inhibitor of metalloproteinases-2 (N-TIMP2). To confer high binding specificity toward one MMP type, we extend one of the N-TIMP2 loops, allowing it to interact with t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2fcd2d5c-3358-5057-9185-e67c484701a4
- DOI
- 10.1101/2022.12.29.522231
